PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma

<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

Jeffrey A. Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi et al. · Science · 2007 · 4.5K citations · Full text

Medicine, Oncology, Pharmacology +17

Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor

Michael C. Heinrich, Christopher L. Corless, George D. Demetri et al. · Journal of Clinical Oncology · 2003 · 2.3K citations

Medicine, Molecular Medicine, Oncology +17

A Tyrosine Kinase Created by Fusion of the <i>PDGFRA</i> and <i>FIP1L1</i> Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

Jan Cools, Daniel J. DeAngelo, Jason Gotlib et al. · New England Journal of Medicine · 2003 · 1.7K citations · Full text

Life Sciences, Genetics, Hematology +15

Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease

William M. Crist, James R. Anderson, Jane L. Meza et al. · Journal of Clinical Oncology · 2001 · 1.1K citations

Medicine, Oncology, Surgery +16

PDGFRαα Signaling Is Regulated through the Primary Cilium in Fibroblasts

Linda Schneider, Christian Clément, Stefan Cuoni Teilmann et al. · Current Biology · 2005 · 581 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +10